v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ 108 $ (6,747)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Share-based compensation expense 11,273 9,630
Depreciation 2,889 2,974
Amortization of intangible assets 2,384 2,110
Amortization of deferred financing costs 105 120
Other non-cash adjustments 708 495
Changes in operating assets and liabilities:    
Accounts receivable (5,019) (2,686)
Inventories (2,770) 750
Other current assets (5,163) (3,885)
Accounts payable 5,572 (722)
Accrued liabilities (13,508) (12,561)
Other noncurrent assets and liabilities (575) (504)
Net cash used in operating activities (3,996) (11,026)
Cash flows from investing activities:    
Purchases of property and equipment (3,852) (2,181)
Proceeds from capital grant 0 500
Net cash used in investing activities (3,852) (1,681)
Cash flows from financing activities:    
Payments on debt, leases and financing obligation (1,194) (287)
Payment of financing costs (777) 0
Shares repurchased for payment of taxes on stock awards (11,442) (10,172)
Proceeds from stock option exercises 158 134
Net cash used in financing activities (13,255) (10,325)
Effect of exchange rate changes on cash and cash equivalents (160) 196
Net decrease in cash and cash equivalents (21,263) (22,836)
Cash and cash equivalents—beginning of period 167,428 122,721
Cash and cash equivalents—end of period 146,165 99,885
Supplemental cash flow information:    
Cash paid for interest 1,220 1,246
Cash paid for taxes, net of refunds 91 116
Non-cash investing and financing activities:    
Accrued purchases of property and equipment $ 1,075 $ 1,156